BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 99 filers reported holding BICYCLE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is 2.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,952,223 | -21.3% | 843,814 | 0.0% | 0.10% | -21.6% |
| Q2 2023 | $21,534,133 | +20.0% | 843,814 | 0.0% | 0.12% | +27.6% |
| Q1 2023 | $17,947,924 | -28.1% | 843,814 | 0.0% | 0.10% | -34.7% |
| Q4 2022 | $24,976,894 | +27.3% | 843,814 | 0.0% | 0.15% | +16.3% |
| Q3 2022 | $19,627,000 | – | 843,814 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |